Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,985 | 286 | 97.2% |
| Education | $204.58 | 8 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $1,335 | 37 | $0 (2024) |
| Amgen Inc. | $684.19 | 24 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $566.68 | 18 | $0 (2019) |
| Relypsa, Inc. | $488.27 | 31 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $457.89 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $403.96 | 20 | $0 (2024) |
| Vifor Pharma, Inc. | $324.60 | 14 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $315.79 | 19 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $279.51 | 8 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $243.25 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,740 | 57 | Bayer Healthcare Pharmaceuticals Inc. ($439.91) |
| 2023 | $1,072 | 37 | Bayer Healthcare Pharmaceuticals Inc. ($361.67) |
| 2022 | $877.53 | 32 | Bayer HealthCare Pharmaceuticals Inc. ($309.53) |
| 2021 | $775.39 | 34 | Bayer HealthCare Pharmaceuticals Inc. ($224.13) |
| 2020 | $467.69 | 22 | Relypsa, Inc. ($129.75) |
| 2019 | $872.11 | 42 | Alexion Pharmaceuticals, Inc. ($166.62) |
| 2018 | $906.05 | 39 | Mallinckrodt LLC ($361.55) |
| 2017 | $479.26 | 31 | Relypsa, Inc. ($141.13) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Nephrology | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Hyperkalemia | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.43 | General |
| 12/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/31/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: CRITICAL CARE | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Nephrology | ||||||
| 09/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: CRITICAL CARE | ||||||
| 08/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Hyperkalemia | ||||||
| 08/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 682 | 1,026 | $355,953 | $100,796 |
| 2022 | 22 | 1,046 | 2,358 | $385,066 | $138,140 |
| 2021 | 24 | 1,273 | 2,325 | $509,148 | $185,411 |
| 2020 | 25 | 1,400 | 2,685 | $609,070 | $187,297 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 32 | 102 | $160,200 | $27,973 | 17.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 39 | 73 | $62,172 | $16,518 | 26.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 135 | $25,808 | $12,798 | 49.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 191 | $25,919 | $11,772 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 134 | $26,628 | $11,701 | 43.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 70 | $25,952 | $9,212 | 35.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $10,788 | $4,416 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,440 | $2,060 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 15 | $4,009 | $1,792 | 44.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 14 | 18 | $3,831 | $1,033 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 52 | $468.00 | $436.80 | 93.3% |
| 80069 | Kidney function blood test panel | Office | 2023 | 32 | 39 | $1,443 | $331.89 | 23.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 36 | 39 | $1,287 | $296.79 | 23.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 39 | 42 | $924.00 | $213.36 | 23.1% |
| 84156 | Total protein level, urine | Office | 2023 | 40 | 45 | $720.00 | $162.00 | 22.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 23 | 26 | $364.00 | $80.86 | 22.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 43 | 148 | $105,228 | $34,627 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 287 | $59,122 | $27,187 | 46.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 31 | 92 | $79,488 | $25,931 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 232 | $32,712 | $13,049 | 39.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 45 | $17,685 | $7,115 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 47 | $13,066 | $6,753 | 51.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 46 | 74 | $14,948 | $6,059 | 40.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $11,940 | $4,605 | 38.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 24 | 25 | $13,275 | $3,987 | 30.0% |
About Dr. Vincent Tjia, MD
Dr. Vincent Tjia, MD is a Nephrology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306803937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Tjia, MD has received a total of $7,190 in payments from pharmaceutical and medical device companies, with $1,740 received in 2024. These payments were reported across 294 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,985).
As a Medicare-enrolled provider, Tjia has provided services to 4,401 Medicare beneficiaries, totaling 8,394 services with total Medicare billing of $611,644. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Austin, TX
- Active Since 04/27/2006
- Last Updated 10/19/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1306803937
Products in Payments
- Kerendia (Drug) $1,335
- Veltassa (Drug) $812.87
- ACTHAR (Biological) $648.08
- KRYSTEXXA (Biological) $347.55
- LOKELMA (Drug) $332.38
- Velphoro (Drug) $300.82
- JYNARQUE (Drug) $262.19
- LUPKYNIS (Drug) $243.25
- Parsabiv (Biological) $212.99
- Auryxia (Drug) $206.32
- BENLYSTA (Biological) $170.28
- SAMSCA (Drug) $141.77
- SOLIRIS (Drug) $141.18
- FARXIGA (Drug) $125.51
- ULTOMIRIS (Biological) $89.49
- JARDIANCE (Drug) $89.00
- FLOWTRIEVER CATHETER, S (Device) $88.08
- RAYALDEE (Drug) $82.40
- TERLIVAZ (Drug) $73.52
- TAVNEOS (Drug) $71.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Austin
Harry Goss, Md, MD
Nephrology — Payments: $215,488
Dr. Michelle Lubetzky, Md, MD
Nephrology — Payments: $33,694
Judith Betts, Md, MD
Nephrology — Payments: $13,254
Margaret Cook, Md, MD
Nephrology — Payments: $10,676
Dr. Andrew Pelphrey, M.d, M.D
Nephrology — Payments: $6,428
Sujatha Venkatesh, Md, MD
Nephrology — Payments: $5,559